| Dr Ingrid Marie Wilson, PHD | |
|
3741 Stocker St, #105, View Park, CA 90008-5109 | |
| (310) 702-8460 | |
| (877) 207-3820 |
| Full Name | Dr Ingrid Marie Wilson |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 3741 Stocker St, View Park, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780890723 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY15620 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ingrid Marie Wilson, PHD 4712 Admiralty Way, 512, Marina Del Rey, CA 90292-6905 Ph: (310) 702-8460 | Dr Ingrid Marie Wilson, PHD 3741 Stocker St, #105, View Park, CA 90008-5109 Ph: (310) 702-8460 |
News Archive
Probactive Biotech, Inc., a Garden Grove, California-based corporation, has entered into an agreement with Dalat Nuclear Research Institute to co-develop a number of cancer drugs, utilizing combinations of antitumor antibodies and antitumor radioactive compounds. Antitumor antibodies have the ability to take antitumor compounds directly to the tumor sites within the body.
For the first time, scientists have described the body's natural mechanism for temporarily protecting the powerhouses of kidney cells when injury or disease means they aren't getting enough blood or oxygen.
Based on the ground-breaking program released in 2005, Homewatch CareGivers (www.HomewatchCareGivers.com), the largest, most experienced international provider of full-service home care, announced the release of its newly expanded Pathways to Memory™ Program, a set of therapeutic activities delivered in a nurturing, failure-free environment that stimulates and enhances cognitive function for patients with early to mid stage dementia, Alzheimer's disease, and other memory loss conditions.
Preliminary clinical trial results from an ongoing Phase 2/3 trial led by Laurent M. Humeau of Inovio Pharmaceuticals suggest the two-dose INO-4800 vaccine is safe for use in adults of varying ages. The results expand on phase 1 trial results that found the vaccine was safe and tolerable in 38 participants.
Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to new research. Results of the multicenter, retrospective study are reported in the June issue of Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).
› Verified 2 days ago
Ms. Marcela Urrutia Hughes, MA PSYCHOLOGY Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5300 Angeles Vista Blvd, View Park, CA 90043 Phone: 323-295-4555 | |
Dr. Juan Manuel Navarro Jr., PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 3741 Stocker St, View Park, CA 90008 Phone: 323-290-5812 |